Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal bypass surgery - PubMed (original) (raw)
Meta-Analysis
Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal bypass surgery
M J Tangelder et al. J Vasc Surg. 1999 Oct.
Free article
Abstract
Purpose: We sought to determine the efficacy of antiplatelet therapy and oral anticoagulants in maintaining graft patency and preventing ischemic complications in patients after infrainguinal bypass surgery.
Methods: We performed a meta-analysis of randomized controlled trials of aspirin with or without other antiplatelet therapy and oral anticoagulants after infrainguinal bypass surgery. Outcome measures studied were graft occlusion, stroke, myocardial infarction, vascular and total mortality, and the composite outcome of stroke, myocardial infarction, and vascular mortality.
Results: Five trials of antiplatelet therapy versus placebo were included. The relative risk (RR) for occlusion was 0.78 (95% CI, 0.64-0.95). For prevention of stroke, myocardial infarction, and death, and for the composite outcome, no significant effect was measured. Only one trial of oral anticoagulants versus control treatment was included. The RR for occlusion was 0.55 (95% CI, 0.30-0.99), and that for amputation was 0.30 (95% CI, 0.10-0.87). The mortality rate did not differ significantly between the groups. One trial of oral anticoagulant therapy plus aspirin versus aspirin alone in high-risk patients was included. The RR for occlusion was 0.38 (95% CI, 0.15-0. 95). There were no significant differences for prevention of amputation, myocardial infarction, and death between the groups.
Conclusion: Antiplatelet therapy and oral anticoagulants reduce the risk of graft occlusion. Oral anticoagulant therapy appears to be the more effective treatment in high-risk patients. Data on the reduction of the risk of stroke, myocardial infarction, and death are inconclusive. Evidence for the beneficial effects of antiplatelet and oral anticoagulant therapy after infrainguinal bypass surgery is based on a small number of trials only. There is no proof as to which modality is the most effective in the prevention of graft occlusion and ischemic events in patients after infrainguinal bypass surgery, which is reason for a randomized comparison of aspirin with oral anticoagulants.
Similar articles
- Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.
Bedenis R, Lethaby A, Maxwell H, Acosta S, Prins MH. Bedenis R, et al. Cochrane Database Syst Rev. 2015 Feb 19;2015(2):CD000535. doi: 10.1002/14651858.CD000535.pub3. Cochrane Database Syst Rev. 2015. PMID: 25695213 Free PMC article. Review. - Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL, Algra A, van Gijn J. De Schryver EL, et al. Cochrane Database Syst Rev. 2003;(1):CD001820. doi: 10.1002/14651858.CD001820. Cochrane Database Syst Rev. 2003. PMID: 12535415 Updated. Review. - Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
Algra A, de Schryver EL, van Gijn J, Kappelle LJ, Koudstaal PJ. Algra A, et al. Cochrane Database Syst Rev. 2001;(4):CD001342. doi: 10.1002/14651858.CD001342. Cochrane Database Syst Rev. 2001. PMID: 11687110 Updated. Review.
Cited by
- Role of the renin-angiotensin system in the pathogenesis of intimal hyperplasia: therapeutic potential for prevention of vein graft failure?
Osgood MJ, Harrison DG, Sexton KW, Hocking KM, Voskresensky IV, Komalavilas P, Cheung-Flynn J, Guzman RJ, Brophy CM. Osgood MJ, et al. Ann Vasc Surg. 2012 Nov;26(8):1130-44. doi: 10.1016/j.avsg.2011.12.001. Epub 2012 Mar 22. Ann Vasc Surg. 2012. PMID: 22445245 Free PMC article. Review. - Rationale and Design of Randomized Clinical Trial for the Assessment of Macitentan Efficiency as Coadjuvant Treatment to Open and Endovascular Revascularization in Critical Limb Ischemia.
Michel I, De Haro J, Bleda S, Laime IV, Uyaguari J, Acin F. Michel I, et al. Clin Med Insights Cardiol. 2016 Nov 3;10:181-185. doi: 10.4137/CMC.S38448. eCollection 2016. Clin Med Insights Cardiol. 2016. PMID: 27840580 Free PMC article. - Peripheral artery disease. Part 2: medical and endovascular treatment.
Weinberg MD, Lau JF, Rosenfield K, Olin JW. Weinberg MD, et al. Nat Rev Cardiol. 2011 Jun 14;8(8):429-41. doi: 10.1038/nrcardio.2011.81. Nat Rev Cardiol. 2011. PMID: 21670746 Review. - Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.
Geraghty AJ, Welch K. Geraghty AJ, et al. Cochrane Database Syst Rev. 2011 Jun 15;2011(6):CD000536. doi: 10.1002/14651858.CD000536.pub2. Cochrane Database Syst Rev. 2011. PMID: 21678330 Free PMC article. Review. - Medical management and cardiovascular risk reduction in peripheral arterial disease.
Sethi A, Arora RR. Sethi A, et al. Exp Clin Cardiol. 2008 Fall;13(3):113-9. Exp Clin Cardiol. 2008. PMID: 19343125 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical